S&P 500 7,510.38 â–ŧ 43.91 (-0.58%) DOW 51,995.32 ▲ 324.29 (+0.63%) NASDAQ 26,374.22 â–ŧ 309.73 (-1.16%) US Markets Closed â€ĸ 12:12 AM ET

RAJAF

CORDYCEPS SUNSHINE BIOTECH HOLD

Price Chart
Latest Quote

$9.18

+0.00 (+0.00%)
Current Price
Previous Close $9.18
Open $3.01
Day High $3.01
Day Low $3.01
Volume 154
Fetched: 2026-06-17T04:12:03
Stock Information
Shares Outstanding 111.12M
Total Debt $693K
Cash Equivalents $15K
Revenue $1.25M
Net Income $-226K
Sector Consumer Defensive
Industry Packaged Foods
Market Cap $1.02B
Exchange OQB
Recent Price History
Date Close Volume
2026-06-16 $9.18 0
2026-06-15 $9.18 0
2026-06-12 $9.18 0
2026-06-11 $9.18 0
2026-06-10 $9.18 0
2026-06-09 $9.18 0
2026-06-08 $9.18 0
2026-06-05 $9.18 0
2026-06-04 $9.18 0
2026-06-03 $9.18 0
2026-06-02 $9.18 0
2026-06-01 $9.18 0
2026-05-29 $9.18 0
2026-05-28 $9.18 0
2026-05-27 $9.18 0
2026-05-26 $9.18 0
2026-05-22 $9.18 0
2026-05-21 $9.18 0
2026-05-20 $9.18 0
2026-05-19 $9.18 0
2026-05-18 $9.18 0
About CORDYCEPS SUNSHINE BIOTECH HOLD

Cordyceps Sunshine Biotech Holdings Co., Ltd. engages in the cultivation and sale of Chinese rare medicinal herb, taiwanofungus raw material, and finished products in China. The company offers Taiwanofungus Oral pill, a pill form dietary supplement; Taiwanofungus Double A Oral shot, TAIWANOFUNGUS x SALVIA MILTIORRHIZA ORAL Shot, and Collagen Max Drink, a liquid form dietary supplement; and Barbie Coco, a chocolate product. It also exports its products to Hong Kong and Mainland China. The company offers its products through online e-commerce platforms, physical chain stores, collaboration with major retail brands, and partnerships with retail channels. Cordyceps Sunshine Biotech Holdings Co., Ltd. was incorporated in 2020 and is based in Taipei, Taiwan.

📰 Latest News
No news articles available at the moment. Check back later for updates on RAJAF.
Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $719,724 $116,146 $13,746 $0
Cost Of Revenue $719,724 $116,146 $13,746 $0
Total Revenue $1,253,484 $882,533 $53,304 $0
Operating Revenue $1,253,484 $882,533 $53,304 $0
Expenses
Interest Expense $17,055 $39,770 $71,772 $0
Total Expenses $1,437,397 $654,700 $468,425 $119,387
Other Income Expense $9,667 $2,752 $-4,855 $-1,138
Other Non Operating Income Expenses $5,339 $2,752 $-4,855 $-1,138
Net Non Operating Interest Income Expense $-17,055 $-39,770 $10 $7
Interest Expense Non Operating $17,055 $39,770 $71,772 $0
Operating Expense $717,673 $538,554 $454,679 $119,387
General And Administrative Expense $717,673 $538,554 $336,235 $94,335
Rent Expense Supplemental - - $68,818 $6,542
Selling And Marketing Expense - - $3,441 $27,298
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-226,258 $169,285 $-415,111 $-119,380
Net Interest Income $-17,055 $-39,770 $10 $7
Normalized Income $-229,720 $169,285 $-415,111 $-119,380
Net Income From Continuing And Discontinued Operation $-226,258 $751,609 $-720,093 $-491,006
Total Operating Income As Reported $-183,913 $227,833 $-415,121 $-119,387
Net Income Common Stockholders $-226,258 $751,609 $-720,093 $-491,006
Net Income $-226,258 $751,609 $-720,093 $-491,006
Net Income Including Noncontrolling Interests $-226,258 $751,609 $-720,093 $-491,006
Net Income Discontinuous Operations $0 $582,324 $-304,982 $-371,626
Net Income Continuous Operations $-226,258 $169,285 $-415,111 $-119,380
Pretax Income $-191,301 $190,815 $-415,111 $-119,380
Special Income Charges $4,328 $0 $0 -
Operating Income $-183,913 $227,833 $-415,121 $-119,387
Gross Profit $533,760 $766,387 $39,558 $0
Interest Income - $7 $10 $7
Interest Income Non Operating - $7 $10 $7
Depreciation Amortization Depletion Income Statement - - $24,760 $420
Depreciation And Amortization In Income Statement - - $24,760 $420
Depreciation Income Statement - - $24,760 $420
Per Share
Diluted EPS - $0.01 $-0.01 $-0.00
Basic EPS - $0.01 $-0.01 $-0.00
Other
Tax Effect Of Unusual Items $866 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $245,484 $287,342 $-390,631 $-114,448
Total Unusual Items $4,328 $0 $0 -
Total Unusual Items Excluding Goodwill $4,328 $0 $0 -
Reconciled Depreciation $424,058 $56,757 $24,490 $4,932
EBITDA (Bullshit earnings) $249,812 $287,342 $-390,631 $-114,448
EBIT $-174,246 $230,585 $-415,121 $-119,380
Diluted NI Availto Com Stockholders $-226,258 $751,609 $-720,093 $-491,006
Tax Provision $34,957 $21,530 $0 $0
Gain On Sale Of Ppe $4,328 $0 $0 -
Research And Development $0 $0 $118,444 $25,052
Selling General And Administration $717,673 $538,554 $336,235 $94,335
Other Gand A $717,673 $538,554 $336,235 $94,335
Diluted Average Shares - $111,120,000 $111,120,000 $111,120,000
Basic Average Shares - $111,120,000 $111,120,000 $111,120,000
Salaries And Wages - $109,295 $110,938 $0
Other Taxes - - $3,588 $4,110
Rent And Landing Fees - - $68,818 $6,542
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-375,543 $-151,796 $-951,334 $-275,813
Total Assets $4,623,704 $3,351,782 $2,104,853 $3,263,038
Total Non Current Assets $4,022,102 $3,024,607 $1,603,301 $2,132,210
Other Non Current Assets $13,175 $14,066 $1,349,625 -
Current Assets $601,602 $327,175 $501,552 $1,130,828
Other Current Assets $57,810 $2,442 - -
Prepaid Assets $201,232 $106,270 $13,603 $27,410
Inventory $304,971 $195,359 $0 $480,352
Receivables $305 $0 $0 $523,382
Accounts Receivable $305 $0 $149,510 $358,006
Cash Cash Equivalents And Short Term Investments $37,284 $23,104 $6,628 $99,684
Cash And Cash Equivalents $37,284 $23,104 $6,628 $99,684
Non Current Deferred Assets - $42,818 $0 -
Non Current Deferred Taxes Assets - $42,818 $0 -
Assets Held For Sale Current - $0 $481,321 -
Taxes Receivable - $106,270 $0 -
Non Current Note Receivables - - $0 $146,040
Other Receivables - - $12,880 $16,476
Allowance For Doubtful Accounts Receivable - - $0 $0
Gross Accounts Receivable - - $149,510 $358,006
Debt
Net Debt $410,871 $407,975 $407,372 $314,316
Total Debt $547,773 $627,526 $592,166 $683,562
Long Term Debt And Capital Lease Obligation $12,602 $537,435 $535,057 $617,325
Current Debt And Capital Lease Obligation $535,171 $90,091 $57,109 $66,237
Current Debt $448,155 - $414,000 -
Other Current Borrowings $448,155 - $414,000 -
Long Term Debt - $431,079 $414,000 $414,000
Liabilities
Total Liabilities Net Minority Interest $4,999,247 $3,503,578 $3,056,187 $3,538,851
Total Non Current Liabilities Net Minority Interest $12,602 $537,435 $535,057 $617,325
Current Liabilities $4,986,645 $2,966,143 $2,521,130 $2,921,526
Payables And Accrued Expenses $4,451,474 $2,876,052 $0 $2,855,289
Payables $4,419,064 $2,849,163 $1,378,277 $2,799,301
Other Payable $3,893,843 $2,605,592 - -
Total Tax Payable $24,006 $21,835 $0 $419
Income Tax Payable $24,006 $21,835 - -
Accounts Payable $276,125 $185,434 $0 $1,227,598
Liabilities Heldfor Sale Non Current - $0 $0 -
Other Current Liabilities - - $1,085,744 -
Equity
Common Stock Equity $-375,543 $-151,796 $-951,334 $-275,813
Total Equity Gross Minority Interest $-375,543 $-151,796 $-951,334 $-275,813
Stockholders Equity $-375,543 $-151,796 $-951,334 $-275,813
Gains Losses Not Affecting Retained Earnings $91,281 $88,770 $40,841 $-3,731
Other Equity Adjustments $91,281 $88,770 $40,841 $-3,731
Retained Earnings $-699,224 $-472,966 $-1,224,575 $-504,482
Other
Ordinary Shares Number $111,120,000 $111,120,000 $111,120,000 $111,120,000
Share Issued $111,120,000 $111,120,000 $111,120,000 $111,120,000
Tangible Book Value $-375,543 $-151,796 $-951,334 $-275,813
Invested Capital $72,612 $279,283 $-537,334 $138,187
Working Capital $-4,385,043 $-2,638,968 $-2,019,578 $-1,790,698
Capital Lease Obligations $99,618 $196,447 $178,166 $269,562
Total Capitalization $-375,543 $279,283 $-537,334 $138,187
Additional Paid In Capital $221,288 $221,288 $221,288 $0
Capital Stock $11,112 $11,112 $11,112 $232,400
Common Stock $11,112 $11,112 $11,112 $232,400
Long Term Capital Lease Obligation $12,602 $106,356 $121,057 $203,325
Current Capital Lease Obligation $87,016 $90,091 $57,109 $66,237
Current Accrued Expenses $32,410 $26,889 $62,754 $55,988
Dueto Related Parties Current $225,090 $36,302 $0 $1,571,284
Net PPE $4,008,927 $3,010,541 $253,676 $1,986,170
Accumulated Depreciation $-472,105 $-81,703 $-24,490 $-179,922
Gross PPE $4,481,032 $3,092,244 $278,166 $2,166,092
Other Properties $99,328 $195,775 $178,166 $272,216
Machinery Furniture Equipment $4,381,704 $2,896,469 $100,000 $1,206,558
Other Inventories $304,971 $195,359 - -
Buildings And Improvements - - $635,040 $687,318
Properties - - $0 $0
Inventories Adjustments Allowances - - $-173,426 $-390,563
Finished Goods - - $207,645 $466,449
Work In Process - - $266,488 $390,588
Raw Materials - - $12,823 $13,878
Duefrom Related Parties Current - - $0 $148,900
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-37,231 $40,237 $-321,378 $-465,363
Operating Activities
Operating Cash Flow $312,006 $359,724 $-321,378 $-365,363
Cash From Discontinued Operating Activities $0 $37,891 $73,473 $-224,716
Cash Flow From Continuing Operating Activities $312,006 $321,833 $-394,851 $-140,647
Operating Gains Losses $-4,328 - - -
Investing Activities
Capital Expenditure $-349,237 $-319,487 $-475 $-100,000
Investing Cash Flow $-305,637 $-319,820 $-475 $-110,815
Cash From Discontinued Investing Activities $0 $-333 $-475 $-10,815
Cash Flow From Continuing Investing Activities $-305,637 $-319,487 $0 $-100,000
Financing Activities
Financing Cash Flow $0 $-32,208 $245,787 $574,504
Cash From Discontinued Financing Activities $0 $-46,851 $-63,476 $246,246
Cash Flow From Continuing Financing Activities $0 $14,643 $309,263 $328,258
Issuance Of Capital Stock - $0 $0 $232,400
Net Other Financing Charges - $14,643 $309,263 $95,858
Net Common Stock Issuance - $0 $0 $232,400
Common Stock Issuance - $0 $0 $232,400
Other
Interest Paid Supplemental Data $150 $0 $0 $0
Income Tax Paid Supplemental Data $20,885 $0 $0 $0
End Cash Position $37,284 $23,104 $16,100 $99,684
Beginning Cash Position $23,104 $16,100 $99,684 $294
Effect Of Exchange Rate Changes $7,811 $-692 $-7,518 $1,064
Changes In Cash $6,369 $7,696 $-76,066 $98,326
Net PPE Purchase And Sale $-305,637 $-319,487 $0 $-100,000
Sale Of PPE $43,600 $0 $0 -
Purchase Of PPE $-349,237 $-319,487 $0 $-100,000
Change In Working Capital $101,802 $61,887 $-4,230 $-26,199
Change In Other Current Liabilities $5,336 $0 $0 $-4,932
Change In Other Current Assets $-48,646 $-449 $-4,230 -
Change In Payables And Accrued Expense $398,377 $362,166 $0 $-10,815
Change In Accrued Expense $7,377 $26,514 $0 $-10,815
Change In Payable $391,000 $335,652 $-122,450 $105,846
Change In Account Payable $104,608 $182,849 $0 $0
Change In Tax Payable $3,629 $21,530 $0 -
Change In Income Tax Payable $3,629 $21,530 $0 -
Change In Prepaid Assets $-131,029 $-104,788 $0 $0
Change In Receivables $-122,236 $-195,042 $0 $-10,452
Changes In Account Receivables $-124,572 $-192,634 $0 $-353,665
Other Non Cash Items $16,732 $33,904 - -
Depreciation Amortization Depletion $424,058 $56,757 $24,490 $4,932
Depreciation And Amortization $424,058 $56,757 $24,490 $4,932
Amortization Cash Flow $16,793 $0 $0 -
Amortization Of Intangibles $16,793 $0 $0 -
Depreciation $407,265 $56,757 $24,490 $4,932
Net Income From Continuing Operations $-226,258 $169,285 $-415,111 $-119,380
Change In Interest Payable - $18,804 $0 $-10,815
Change In Inventory - $-192,634 $48,833 $0
Deferred Tax - $-42,221 $0 $0
Deferred Income Tax - $-42,221 $0 $0
Repayment Of Debt - - $-151,423 $-240,702
Issuance Of Debt - - $0 $0
Net Issuance Payments Of Debt - - $0 $0
Net Short Term Debt Issuance - - $245,787 $342,104
Short Term Debt Payments - - $-151,423 $-240,702
Short Term Debt Issuance - - $397,210 $582,806
Net Long Term Debt Issuance - - $0 $0
Long Term Debt Issuance - - $0 $0
Asset Impairment Charge - - $85,886 $385,828
Fetched: 2026-02-02